Stocks To Watch On May 28: Indian headline indices slipped in the red on Monday after hitting fresh lifetime highs dragged by FMCG, metals and energy stocks. While the S&P BSE Sensex scaled 76,009.68 before closing the session at 75,390.50, down by 19.89 points or 0.03%, the broader Nifty finished at 22,932.45, lower by 24.65 points or 0.11%.
In today’s trading session, Indian Railway Catering and Tourism Corporation (IRCTC), Aditya Birla Fashion and Retail (ABFRL), Vedanta, Timken, National Aluminium Company, Adani Energy Solutions and CMS Info Systems, among others will be in focus due to various related developments or quarterly earnings.
IRCTC, Aditya Birla Fashion, GIC, Amara Raja Energy & Mobility, Aster DM Healthcare, Campus Activewear, Eureka Forbes, RITES
As many as 453 companies are due to post their quarterly results. Among them will be IRCTC, ABFRL, JSW Holdings, GIC, NBCC, Amara Raja Energy & Mobility, Aster DM Healthcare, Campus Activewear, Eureka Forbes and RITES Ltd.
Life Insurance Corporation of India: It reported a 15.6 per cent year on year (YoY) increase in standalone net premium income, reaching Rs 1.52 lakh crore in Q4FY24 compared to Rs 1.32 lakh crore. Despite a slight dip in VNB margins to 17.2 per cent from 17.5 per cent, the annualised premium equivalent (APE) witnessed a 3 per cent YoY growth, totaling Rs 21,180 crore versus Rs 20,592 crore. Net profit saw a marginal uptick of 2.5 per cent to Rs 13,763 crore from Rs 13,428 crore, with the board recommending a final dividend of Rs 6 per share.
Lumax Auto Technologies: The company’s revenue jumped by 53.5 per cent YoY to Rs 757 crore in Q4FY24 from Rs 493 crore in Q4FY23. Ebitda rose by 62.2 per cent to Rs 92 crore from Rs 57 crore, leading to a slight increase in margins to 12.1 per cent from 11.5 per cent. Net profit stood at Rs 51 crore in Q4FY24 compared to Rs 24 crore in Q4FY23.
Astrazeneca Pharma: The pharma company reported a 34.6 per cent YoY increase in revenue to Rs 383 crore in Q4FY24 from Rs 285 crore in Q4FY23. However, Ebitda witnessed a decline of 17.6 per cent YoY to Rs 49 crore from Rs 60 crore, resulting in a contraction in margins from 21 per cent in Q4FY23 to 12.9 per cent in Q4FY24. Despite this, net profit surged by an impressive 129 per cent to Rs 39 crore from Rs 17 crore.
Natco Pharma: It showcased a 19 per cent YoY growth in consolidated revenue to Rs 1,068 crore in Q4FY24 compared to Rs 898 crore. Ebitda surged by 46.7 per cent YoY to Rs 497 crore in Q4FY24 from Rs 339 crore, driving an improvement in margins to 46.6 per cent from 37.8 per cent. Net profit soared by 40.1 per cent YoY to Rs 386 crore in March quarter from Rs 276 crore in the same quarter of the previous year.
Vedanta: Indian commodities tycoon Anil Agarwal’s Vedanta Ltd. is considering a share sale as soon as the coming weeks that could raise as much as 85 billion rupees ($1 billion), people with knowledge of the matter said. The mining major is working with advisers including Axis Bank subsidiary Axis Capital and Citigroup Inc. on the offering, the people said.
NALCO: State-owned Nalco on Monday reported a two-fold rise in consolidated profit to Rs 996.74 crore for the March quarter on the back of lower expenses. The company had posted a consolidated profit of Rs 495 crore in the March quarter of FY23, National Aluminium Company Ltd (Nalco) said in a filing to the BSE. However, the consolidated total income during the quarter dropped to Rs 3,663.09 crore from Rs 3,726.76 crore in the year-ago period.
CMS Info Systems: The stock will be in focus as Tuesday will be the ex-date and record date for company dividend which has been declared at Rs 3.25 per share.
Comments
0 comment